Malaysia’s reproductive medicine has reached a new zenith with the introduction of Ovarian Tissue Cryopreservation (OTC) at Sunfert International Fertility Centre, a pioneering step in oncofertility. This groundbreaking technique, first initiated in Europe over two decades ago, marks Malaysia’s significant progress in helping female cancer patients preserve their fertility. Dr Wong Pak Seng, the visionary behind Sunfert, described OTC as a life-altering solution for women and young patients facing cancer, enabling them to uphold their future dream of parenthood.
The procedure involves a laparoscopic method to harvest and freeze ovarian tissue, a process devoid of medication, thus sidestepping potential side effects. Its swift execution, taking only 15-20 minutes, adds to its appeal. The preserved tissue can be stored for up to two decades at -190 degrees Celsius and is ready for transplantation once the patient is cancer-free.
Associate Professor Dr. Mohd Faizal bin Ahmad highlighted OTC’s suitability for pre-pubescent girls without mature eggs and women needing urgent cancer treatments. He pointed out the procedure’s edge over other methods like embryo and egg freezing, stressing its minimal invasiveness and time efficiency. Dr Mohd Faizal also emphasized the importance of fertility preservation, particularly for young cancer patients, in maintaining life quality post-treatment.
OTC’s emergence brings hope to numerous women diagnosed with cancer annually, especially given the rising survival rates due to advanced treatments. The future of oncofertility looks promising, with potential governmental support and financial aid for underprivileged patients in Malaysia, as envisioned by Dr Mohd Faizal. This advancement not only addresses survival but also improves the overall life outcomes for cancer patients.
Read more here.